MetroBiotech

Q: What is MetroBiotech's official website?

MetroBiotech's official website is www.metrobiotech.com

Q: What is MetroBiotech's Revenue?

MetroBiotech's revenue is <$5 Million

Q: How many employees does MetroBiotech have?

MetroBiotech has 11-50 employees

Q: What industry does MetroBiotech belong to?

MetroBiotech is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is MetroBiotech competition?

MetroBiotech top competitors include: Melior Discovery , Hepion Pharmaceuticals , Cellectar Biosciences , American Gene Technologies International

Q: What technology does MetroBiotech use?

Some of the popular technologies that MetroBiotech uses are: WordPress.org, PHP, YouTube, Microsoft 365

Q: What does MetroBiotech do?

MetroBiotech, LLC is a clinical-stage pharmaceutical company focused on developing proprietary NAD+ precursors to enhance human healthspan and address age-related diseases. The company is advancing a portfolio of innovative therapeutics, including its lead candidate MIB-626, which is currently in Phase 2 clinical trials for various conditions such... as Alzheimer's disease and chronic kidney disease. MetroBiotech aims to restore NAD+ levels, which decline with age, to improve health and metabolism, backed by a world-class scientific advisory board. Their commitment to pharmaceutical-grade manufacturing ensures the safety and efficacy of their products. Read More

Q: Is MetroBiotech a public company?

MetroBiotech is private company therefore does not currently have an official ticker symbol

Manufacturing · 11-50 Employees

View Company Info for Free

Overview

Website

www.metrobiotech.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About MetroBiotech

MetroBiotech, LLC is a clinical-stage pharmaceutical company focused on developing proprietary NAD+ precursors to enhance human healthspan and address age-related diseases. The company is advancing a portfolio of innovative therapeutics, including its lead candidate MIB-626, which is currently in Phase 2 clinical trials for various conditions such as Alzheimer's disease and chronic kidney disease. MetroBiotech aims to restore NAD+ levels, which decline with age, to improve health and metabolism, backed by a world-class scientific advisory board. Their commitment to pharmaceutical-grade manufacturing ensures the safety and efficacy of their products.Explore more

Is this data correct?

View contact profiles from MetroBiotech

SIC Code 28,283NAICS Code 32,325Show more

MetroBiotech Org Chart

Phone

David Livingston

President & Chief Scientific Officer

Phone

Get the full picture

Compare Similar Companies to MetroBiotech

Compare insights from companies similar to MetroBiotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.